FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322866056> ?p ?o ?g. }

• W2322866056 endingPage "904" @default.
• W2322866056 startingPage "897" @default.
• W2322866056 abstract "Improving the antitumor potency of current oncolytic adenoviruses represents one of the major challenges in development of these viruses for clinical use. We have generated an oncolytic adenovirus carrying the safety-enhancing E1AΔ24 deletion, the potency-enhancing T1 mutation, and the infectivity-enhancing fiber RGD modification. The results of in vitro cytotoxicity assays on 15 human cancer cell lines derived from different tumor types demonstrated that ORCA-010 is more potent than Ad5-Δ24RGD or ONYX-015. As ORCA-010 will initially be developed for the treatment of prostate cancer, selectivity experiments were performed using primary human prostate cells. ORCA-010 killed cancer cells more effectively than these primary human cells. In both primary prostate fibroblasts and epithelial cells, ORCA-010 was as safe as Ad5-Δ24RGD. Evaluation of ORCA-010 in in vivo xenograft tumor models in nude mice showed that ORCA-010 significantly inhibited growth of prostate, lung, and ovarian tumors and conferred prolonged survival of tumor-bearing animals. Furthermore, we observed a substantial increase in infectious viral particles in tumors injected with ORCA-010. The number of infectious viral particles increased after treatment and infectious particles remained present up to at least 4 weeks posttreatment. Intratumoral virus replication was associated with substantial necrosis and fibrosis. In conclusion, ORCA-010 is more potent than earlier generation oncolytic adenoviruses, without demonstrating increased toxicity. ORCA-010 exerted strong in vivo antitumor activity and is therefore a suitable candidate for clinical evaluation." @default.
• W2322866056 created "2016-06-24" @default.
• W2322866056 creator A5035586057 @default.
• W2322866056 creator A5039915003 @default.
• W2322866056 creator A5042146159 @default.
• W2322866056 creator A5067522044 @default.
• W2322866056 creator A5076075547 @default.
• W2322866056 creator A5085418071 @default.
• W2322866056 date "2014-10-01" @default.
• W2322866056 modified "2023-10-17" @default.
• W2322866056 title "ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models" @default.
• W2322866056 cites W1491631791 @default.
• W2322866056 cites W1965295123 @default.
• W2322866056 cites W1978298636 @default.
• W2322866056 cites W2005313857 @default.
• W2322866056 cites W2016080258 @default.
• W2322866056 cites W2029437600 @default.
• W2322866056 cites W2038591876 @default.
• W2322866056 cites W2050934472 @default.
• W2322866056 cites W2057164082 @default.
• W2322866056 cites W2061955274 @default.
• W2322866056 cites W2110592777 @default.
• W2322866056 cites W2138184512 @default.
• W2322866056 cites W2142321935 @default.
• W2322866056 cites W2147649350 @default.
• W2322866056 cites W2147961945 @default.
• W2322866056 cites W2322389503 @default.
• W2322866056 cites W2326100730 @default.
• W2322866056 cites W4211238487 @default.
• W2322866056 doi "https://doi.org/10.1089/hum.2013.229" @default.
• W2322866056 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4180126" @default.
• W2322866056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25093639" @default.
• W2322866056 hasPublicationYear "2014" @default.
• W2322866056 type Work @default.
• W2322866056 sameAs 2322866056 @default.
• W2322866056 citedByCount "23" @default.
• W2322866056 countsByYear W23228660562015 @default.
• W2322866056 countsByYear W23228660562016 @default.
• W2322866056 countsByYear W23228660562017 @default.
• W2322866056 countsByYear W23228660562018 @default.
• W2322866056 countsByYear W23228660562019 @default.
• W2322866056 countsByYear W23228660562020 @default.
• W2322866056 countsByYear W23228660562021 @default.
• W2322866056 countsByYear W23228660562022 @default.
• W2322866056 countsByYear W23228660562023 @default.
• W2322866056 crossrefType "journal-article" @default.
• W2322866056 hasAuthorship W2322866056A5035586057 @default.
• W2322866056 hasAuthorship W2322866056A5039915003 @default.
• W2322866056 hasAuthorship W2322866056A5042146159 @default.
• W2322866056 hasAuthorship W2322866056A5067522044 @default.
• W2322866056 hasAuthorship W2322866056A5076075547 @default.
• W2322866056 hasAuthorship W2322866056A5085418071 @default.
• W2322866056 hasBestOaLocation W23228660562 @default.
• W2322866056 hasConcept C104317684 @default.
• W2322866056 hasConcept C109316439 @default.
• W2322866056 hasConcept C111599444 @default.
• W2322866056 hasConcept C121608353 @default.
• W2322866056 hasConcept C126322002 @default.
• W2322866056 hasConcept C150903083 @default.
• W2322866056 hasConcept C159047783 @default.
• W2322866056 hasConcept C202751555 @default.
• W2322866056 hasConcept C207001950 @default.
• W2322866056 hasConcept C2522874641 @default.
• W2322866056 hasConcept C2776954459 @default.
• W2322866056 hasConcept C2777283488 @default.
• W2322866056 hasConcept C2780192828 @default.
• W2322866056 hasConcept C49744831 @default.
• W2322866056 hasConcept C502942594 @default.
• W2322866056 hasConcept C54355233 @default.
• W2322866056 hasConcept C55493867 @default.
• W2322866056 hasConcept C57992300 @default.
• W2322866056 hasConcept C71924100 @default.
• W2322866056 hasConcept C81885089 @default.
• W2322866056 hasConcept C82210918 @default.
• W2322866056 hasConcept C86803240 @default.
• W2322866056 hasConceptScore W2322866056C104317684 @default.
• W2322866056 hasConceptScore W2322866056C109316439 @default.
• W2322866056 hasConceptScore W2322866056C111599444 @default.
• W2322866056 hasConceptScore W2322866056C121608353 @default.
• W2322866056 hasConceptScore W2322866056C126322002 @default.
• W2322866056 hasConceptScore W2322866056C150903083 @default.
• W2322866056 hasConceptScore W2322866056C159047783 @default.
• W2322866056 hasConceptScore W2322866056C202751555 @default.
• W2322866056 hasConceptScore W2322866056C207001950 @default.
• W2322866056 hasConceptScore W2322866056C2522874641 @default.
• W2322866056 hasConceptScore W2322866056C2776954459 @default.
• W2322866056 hasConceptScore W2322866056C2777283488 @default.
• W2322866056 hasConceptScore W2322866056C2780192828 @default.
• W2322866056 hasConceptScore W2322866056C49744831 @default.
• W2322866056 hasConceptScore W2322866056C502942594 @default.
• W2322866056 hasConceptScore W2322866056C54355233 @default.
• W2322866056 hasConceptScore W2322866056C55493867 @default.
• W2322866056 hasConceptScore W2322866056C57992300 @default.
• W2322866056 hasConceptScore W2322866056C71924100 @default.
• W2322866056 hasConceptScore W2322866056C81885089 @default.
• W2322866056 hasConceptScore W2322866056C82210918 @default.
• W2322866056 hasConceptScore W2322866056C86803240 @default.
• W2322866056 hasIssue "10" @default.

• next